These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1197060)

  • 1. [Pigment cirrhosis of the liver. I. Wilson's disease--hepatolenticular degeneration].
    Koziolowa H; Dziezbicka E
    Pol Arch Med Wewn; 1975 Nov; 54(5):491-5. PubMed ID: 1197060
    [No Abstract]   [Full Text] [Related]  

  • 2. [Penicillamine treatment of Wilson's disease].
    Falkmer S; Samuelson G; Sjölin S
    Lakartidningen; 1969 May; 66(20):2097-105. PubMed ID: 5795695
    [No Abstract]   [Full Text] [Related]  

  • 3. Abnormalities of the physiology of copper in Wilson's disease. 3. The excretion of copper.
    O'Reilly S; Weber PM; Oswald M; Shipley L
    Arch Neurol; 1971 Jul; 25(1):28-32. PubMed ID: 5146408
    [No Abstract]   [Full Text] [Related]  

  • 4. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
    Falkmer S; Samuelson G; Sjölin S
    Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormalities of the physiology of copper in Wilson's disease. I. The whole-body turnover of copper.
    O'Reilly S; Strickland GT; Weber PM; Beckner WM; Shipley L
    Arch Neurol; 1971 May; 24(5):385-90. PubMed ID: 5554862
    [No Abstract]   [Full Text] [Related]  

  • 6. Turnover studies of copper in homozygotes and heterozygotes for Wilson's disease and controls: isotope tracer studies with 67 Cu.
    Strickland GT; Beckner WM; Leu ML; O'Reilly S
    Clin Sci; 1972 Nov; 43(5):605-15. PubMed ID: 5083936
    [No Abstract]   [Full Text] [Related]  

  • 7. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
    Lange J; Brandt G
    Med Welt; 1981 Jan; 32(3):109-10. PubMed ID: 7207132
    [No Abstract]   [Full Text] [Related]  

  • 8. Wilson's disease.
    Ala A; Walker AP; Ashkan K; Dooley JS; Schilsky ML
    Lancet; 2007 Feb; 369(9559):397-408. PubMed ID: 17276780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of cirrhosis in Wilson's disease.
    Sternlieb I
    Clin Gastroenterol; 1975 May; 4(2):367-79. PubMed ID: 1092490
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal abnormalities in heterozygotes for Wilson's disease: genes or copper?
    Strickland GT; Leu ML
    Am J Med Sci; 1972 Aug; 264(2):157-60. PubMed ID: 4653120
    [No Abstract]   [Full Text] [Related]  

  • 11. [Wilson's disease (hepatolenticular degeneration)].
    Ferrer S; Grismali J; Vergara F; Madrid R; Colombo M
    Rev Med Chil; 1968 Dec; 96(12):779-88. PubMed ID: 5732518
    [No Abstract]   [Full Text] [Related]  

  • 12. Introduction. Symposium on copper metabolism and Wilson's disease.
    Goldstein NP; Owen CA
    Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of Wilson's disease by penicillamine?
    Lancet; 1968 May; 1(7550):1021-2. PubMed ID: 4171810
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
    Marecek Z; Heyrovský A; Volek V
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wilson's disease. Hepatic manifestations].
    Oliveira e Silva A; Roldan Molina LF; dos Santos TE; Santo GC; Gama-Rodrigues JJ; D'Albuquerque LA
    Arq Gastroenterol; 1989; 26(3):47-9. PubMed ID: 2697201
    [No Abstract]   [Full Text] [Related]  

  • 16. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of Wilson's disease in sibs of a patient with Wilson's disease.
    Kamoun P; Cadoudal M; Rabier D; Jérôme H
    Clin Chem; 1986 Feb; 32(2):392. PubMed ID: 3943210
    [No Abstract]   [Full Text] [Related]  

  • 18. Wilson's disease (hepatolenticular degeneration) of late adult onset: report of case.
    Fitzgerald MA; Gross JB; Goldstein NP; Wahner HW; McCall JT
    Mayo Clin Proc; 1975 Aug; 50(8):438-42. PubMed ID: 1152537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption of copper in homozygotes and heterozygotes for Wilson's disease and controls: isotope tracer studies with 67 Cu and 64 Cu.
    Strickland GT; Beckner WM; Leu ML
    Clin Sci; 1972 Nov; 43(5):617-25. PubMed ID: 5083937
    [No Abstract]   [Full Text] [Related]  

  • 20. [Proceedings: Differentiation of homozygote and heterozygote, therapy and follow-up study in 4 families with Wilson's disease].
    Abendschein Th; Przuntek H; Wesch H; Gäng V
    MMW Munch Med Wochenschr; 1975 May; 117(20):842. PubMed ID: 805973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.